135 related articles for article (PubMed ID: 33194326)
1. Proteomic analysis of human cervical adenocarcinoma mucus to identify potential protein biomarkers.
Ma Z; Chen J; Luan T; Chu C; Wu W; Zhu Y; Gu Y
PeerJ; 2020; 8():e9527. PubMed ID: 33194326
[TBL] [Abstract][Full Text] [Related]
2. Label-Free Quantitative Comparison of Cervical Mucus Peptides in Subjects With Endocervical Adenocarcinoma and Adenocarcinoma in Situ.
Shi F; Li X; Ma Z; Luan T; Zhong T; Gu Y
Technol Cancer Res Treat; 2021; 20():1533033821997825. PubMed ID: 33612089
[TBL] [Abstract][Full Text] [Related]
3. Endocervical adenocarcinoma in situ-from Papanicolaou test to hysterectomy: a series of 74 cases.
Lashmanova N; Braun A; Cheng L; Gattuso P; Yan L
J Am Soc Cytopathol; 2022; 11(1):13-20. PubMed ID: 34509373
[TBL] [Abstract][Full Text] [Related]
4. Cervical mucus proteome in endometriosis.
Grande G; Vincenzoni F; Milardi D; Pompa G; Ricciardi D; Fruscella E; Mancini F; Pontecorvi A; Castagnola M; Marana R
Clin Proteomics; 2017; 14():7. PubMed ID: 28174513
[TBL] [Abstract][Full Text] [Related]
5. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a set of biomarkers of human lung adenocarcinoma through cell-map proteomics and bioinformatics.
Nan Y; Jin F; Yang S; Tian Y; Xie Y; Fu E; Yu H
Med Oncol; 2010 Dec; 27(4):1398-406. PubMed ID: 20041319
[TBL] [Abstract][Full Text] [Related]
7. Personalized Medicine and Cervical Screening: Development of Individualized Quantitative Risk Assessments for Cervical Adenocarcinoma and Adenocarcinoma in situ.
Jones TE; Onisko A; Austin RM
Acta Cytol; 2021; 65(2):158-164. PubMed ID: 33260179
[TBL] [Abstract][Full Text] [Related]
8. Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.
Lee S; Rose MS; Sahasrabuddhe VV; Zhao R; Duggan MA
Int J Gynecol Pathol; 2017 Jul; 36(4):310-322. PubMed ID: 27801764
[TBL] [Abstract][Full Text] [Related]
9. Quantitative proteomic analysis of cervical cancer based on TMT-labeled quantitative proteomics.
Xu D; Zhu X; Ren J; Huang S; Xiao Z; Jiang H; Tan Y
J Proteomics; 2022 Feb; 252():104453. PubMed ID: 34915198
[TBL] [Abstract][Full Text] [Related]
10. Potential predictive plasma biomarkers for cervical cancer by 2D-DIGE proteomics and Ingenuity Pathway Analysis.
Guo X; Hao Y; Kamilijiang M; Hasimu A; Yuan J; Wu G; Reyimu H; Kadeer N; Abudula A
Tumour Biol; 2015 Mar; 36(3):1711-20. PubMed ID: 25427637
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the levels of CA125, carcinoembryonic antigen, and CA19-9 in the cervical mucus for a detection of cervical adenocarcinoma.
Fujii S; Konishi I; Nanbu Y; Nonogaki H; Kobayashi F; Sagawa N; Mori T; Endo K
Cancer; 1988 Aug; 62(3):541-7. PubMed ID: 2455590
[TBL] [Abstract][Full Text] [Related]
12. Proteomic profiling of yellow catfish (Pelteobagrus fulvidraco) skin mucus identifies differentially-expressed proteins in response to Edwardsiella ictaluri infection.
Xiong Y; Dan C; Ren F; Su Z; Zhang Y; Mei J
Fish Shellfish Immunol; 2020 May; 100():98-108. PubMed ID: 32142873
[TBL] [Abstract][Full Text] [Related]
13. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of high-grade dysplastic cervical cells obtained from ThinPrep slides using laser capture microdissection and mass spectrometry.
Gu Y; Wu SL; Meyer JL; Hancock WS; Burg LJ; Linder J; Hanlon DW; Karger BL
J Proteome Res; 2007 Nov; 6(11):4256-68. PubMed ID: 17902640
[TBL] [Abstract][Full Text] [Related]
15. Discovery of pathway biomarkers from coupled proteomics and systems biology methods.
Zhang F; Chen JY
BMC Genomics; 2010 Nov; 11 Suppl 2(Suppl 2):S12. PubMed ID: 21047379
[TBL] [Abstract][Full Text] [Related]
16. Proteomic identification of predictive tissue biomarkers of sensitive to neoadjuvant chemotherapy in squamous cervical cancer.
Guo L; Zhang C; Zhu J; Yang Y; Lan J; Su G; Xie X
Life Sci; 2016 Apr; 151():102-108. PubMed ID: 26947588
[TBL] [Abstract][Full Text] [Related]
17. A proteomic profiling of laser-microdissected lung adenocarcinoma cells of early lepidic-types.
Kato Y; Nakamura H; Tojo H; Nomura M; Nagao T; Kawamura T; Kodama T; Ohira T; Ikeda N; Fehniger T; Marko-Varga G; Nishimura T; Kato H
Clin Transl Med; 2015 Dec; 4(1):64. PubMed ID: 26162278
[TBL] [Abstract][Full Text] [Related]
18. Proteomic assessment of markers for malignancy in the mucus of intraductal papillary mucinous neoplasms of the pancreas.
Corcos O; Couvelard A; Dargère D; Sauvanet A; Hammel P; Paradis V; Lévy P; Ruszniewski P; Bedossa P
Pancreas; 2012 Mar; 41(2):169-74. PubMed ID: 22076567
[TBL] [Abstract][Full Text] [Related]
19. Quantitative Proteomic Analysis of Cervical Cancer Tissues Identifies Proteins Associated With Cancer Progression.
Ramírez-Torres A; Gil J; Contreras S; Ramírez G; Valencia-González HA; Salazar-Bustamante E; Gómez-Caudillo L; García-Carranca A; Encarnación-Guevara S
Cancer Genomics Proteomics; 2022; 19(2):241-258. PubMed ID: 35181591
[TBL] [Abstract][Full Text] [Related]
20. Protection against squamous cell carcinoma and cervical adenocarcinoma afforded by cervical cytology screening: a cross-sectional study.
Vale DB; Braganca JF; Morais SS; Zeferino LC
Int J Gynecol Cancer; 2014 Feb; 24(2):321-8. PubMed ID: 24407579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
